多模态扩散MRI与VI-RADS协同用于膀胱尿路上皮癌精确分级:一项前瞻性诊断模型验证
前瞻性纳入2023年5月至12月病理确诊的膀胱尿路上皮癌患者50例(低级别16例、高级别34例),评估DTI、DKI、MAP、NODDI及VI-RADS鉴别病理分级的效能。VI-RADS评分与DKI-MK为独立预测因子,二者联合AUC达0.915、敏感度0.941,优于VI-RADS单独(AUC 0.692、敏感度0.471)或ADC单独(AUC 0.787、敏感度0.813)。
要点
- DKI-MK鉴别低级别与高级别膀胱尿路上皮癌的AUC为0.865,VI-RADS评分AUC为0.692。
- VI-RADS联合DKI-MK的AUC为0.915、敏感度0.941,优于VI-RADS单独或ADC单独。
- VI-RADS评分与DKI-MK均为鉴别低级别与高级别膀胱尿路上皮癌的独立预测因子。
核心结论
- 将VI-RADS与DKI-MK整合可显著提升膀胱尿路上皮癌术前病理分级的评估效能,准确性与敏感度均高于VI-RADS或ADC单独使用。
研究设计与样本
- 前瞻性诊断模型验证研究,纳入2023年5月至12月病理确诊的膀胱尿路上皮癌患者50例(低级别16例、高级别34例)。
诊断标准与关键数值
- VI-RADS评分鉴别低级别与高级别膀胱尿路上皮癌的AUC为0.692,敏感度为0.471。
- DKI-MK鉴别低级别与高级别膀胱尿路上皮癌的AUC为0.865。
- VI-RADS联合DKI-MK的AUC为0.915、敏感度为0.941,优于VI-RADS单独(AUC 0.692、敏感度0.471;p < 0.001)。
- VI-RADS联合DKI-MK优于ADC单独(AUC 0.787、敏感度0.813;p < 0.05)。
临床应用与阅片要点
- 作者认为,将定性影像标准(VI-RADS)与定量扩散指标(DKI-MK)结合可提高诊断客观性,并可能对治疗分层有临床实用价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the diagnostic performance of diffusion tensor imaging (DTI), diffusion kurtosis imaging (DKI), mean apparent propagator (MAP), neurite orientation dispersion and density imaging (NODDI), and the Vesical Imaging-Reporting and Data System (VI-RADS) in discriminating the pathological grade of bladder urothelial carcinoma (UCB).
MATERIALS AND METHODS: This prospective study enrolled patients with pathologically confirmed UCB between May 2023 and December 2023. Preoperative MRI protocols included spin-echo echo-planner imaging (SE-EPI) and conventional DWI. Quantitative parameters from SE-EPI (DTI, DKI, MAP, NODDI) and apparent diffusion coefficient (ADC) values were measured. Group comparisons between low-grade and high-grade UCB were performed using t-tests or Mann-Whitney U tests. Receiver operating characteristic (ROC) analysis and DeLong's test were used to evaluate diagnostic performance.
RESULTS: A total of 50 patients with UCB (low-grade/ high-grade = 16/34) were included. VI-RADS score and mean kurtosis (MK) derived from DKI emerged as independent predictors for differentiating low-grade and high-grade UCB (area under the curve (AUC): 0.692 and 0.865, respectively). The combination of VI-RADS and DKI-MK achieved superior diagnostic performance (AUC: 0.915, sensitivity: 0.941) compared to VI-RADS alone (AUC: 0.692, sensitivity: 0.471; p < 0.001) or ADC alone (AUC: 0.787, sensitivity: 0.813; p < 0.05).
CONCLUSION: Integrating VI-RADS with DKI-MK significantly enhances preoperative assessment of UCB pathological grading, demonstrating higher accuracy and sensitivity than VI-RADS or ADC alone. This approach improves diagnostic objectivity by combining qualitative imaging criteria with quantitative diffusion metrics, offering potential clinical utility for treatment stratification.
引用
- Zhang X, Wang S, Wang M, et al. Multimodal Diffusion MRI Synergized with VI-RADS for Precision Grading of Bladder Urothelial Carcinoma: A Prospective Diagnostic Model Validation. Acad Radiol. 2025. PMID: 40425435. doi:10.1016/j.acra.2025.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。